You are here

  • Home
  • Online First
  • Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer

Article metrics

Article menu

other Versions

Original research
Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer

 

Online download statistics by month:

Online download statistics by month: June 2022 to March 2023

AbstractFullPdf
Jun 202215715949
Jul 202215815558
Aug 202232231638
Sep 202219519747
Oct 202217016815
Nov 2022959118
Dec 2022615918
Jan 2023383615
Feb 202368698
Mar 2023383510
Total13021285276